WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-20·Latest →

Amgen (AMGN) Stock Analysis

HOLD

AMGN Equity Research — HOLD — July 2026

← ABTBMY →

Rating date

Jul 20, 2026

21 days ago

Desk view

HOLD

5D move

—

Neutral (HOLD unscored)

Peer rank

67p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · AMGN

Here is the analysis for AMGN as of July 20, 2026.

Desk rating

HOLD

Tactical HOLD · 12M HOLD

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

HOLD

Catalysts

  • Long-term uptrend intact: AMGN is solidly above both its 50- and 200-day SMAs, with a widening golden-cross structure — a textbook bullish configuration.
  • Neutral momentum, not extreme: The RSI at ~55.7 is comfortably in the middle band, giving the stock room to move in either direction without being overbought or oversold.
  • Short-term consolidation: July price action shows a volatile range between ~$354 and ~$378. The stock has been unable to sustain a close above $374, despite probing above $378 intraday.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

AMGN Research Note

Full desk note for Jul 20, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

21 min read

WebserviceX · Agentic Research Desk

AMGN Equity Research Note

Published Jul 20, 2026 · Desk view HOLD · Generated 2026-07-21T15:32:30Z · Maintained by Walter Vijayakumar · Methodology · Track record

AMGN Stock Rating Summary

AMGN bias

HOLD

Horizon

Short to medium term

AMGN key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

AMGN catalyst watch

Long-term uptrend intact: AMGN is solidly above both its 50- and 200-day SMAs, with a widening golden-cross structure — a textbook bullish configuration.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Neutral (HOLD unscored)Peer 67p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-21T15:52:16.097978+00:00.

5D move

—

2026-07-20 → awaiting

Outcome

Neutral (HOLD unscored)

5D trend

+1.03%

Vol (20D ann.)

+23.72%

vs SPY: +1.98%

Close 364.17 → — (USD, vendor closes)

Batch scorecard · 2026-07-20 · AMGN

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 1087c64c…

No QC issues recorded.